Target Name: STAM2
NCBI ID: G10254
Review Report on STAM2 Target / Biomarker Content of Review Report on STAM2 Target / Biomarker
STAM2
Other Name(s): signal transducing adaptor molecule (SH3 domain and ITAM motif) 2 | signal transducing adaptor molecule 2 | STAM-2 | STAM-like protein containing SH3 and ITAM domains 2 | STAM2_HUMAN | Hrs-binding protein | HSE1 homolog | STAM2A | STAM2B | Hbp | Signal transducing adapter molecule 2 | Signal transducing adaptor molecule 2

Signal Transducing Adaptor Molecule (STAM2): A Potential Drug Target and Biomarker

Stem cells are a crucial cell type that have the ability to develop into various tissues in the body. These cells have the potential to regenerate lost tissue and repair damaged cells, making them an attractive target for drug development. Signal transducing adaptor molecules (STAMs) have been identified as potential drug targets due to their unique structure and function. In this article, we will focus on the STAM2 molecule, which has the potential to be a drug target or biomarker.

Structure and Function of STAM2

The STAM2 molecule was identified as a protein that contains a SH3 domain and an ITAM motif. The SH3 domain is a conserved protein that is involved in protein-protein interactions and can modulate protein stability. The ITAM motif is a unique protein-protein interaction that is found in a variety of organisms, including humans. It is involved in protein-protein interactions and can play a role in regulating protein stability.

The STAM2 molecule is a 21 kDa protein that is expressed in various tissues, including the brain, heart, and gastrointestinal tract. It is localized to the endoplasmic reticulum (ER) and is predominantly expressed in the cytoplasm. The STAM2 molecule is capable of forming a stable complex with various protein partners, including casein kinase (CK) 1 (CK-1), casein kinase 2 (CK-2), and the protein kinase B (PKB).

STAM2's Potential as a Drug Target

The STAM2 molecule has been identified as a potential drug target due to its unique structure and function. One of the reasons for its potential as a drug target is its involvement in various signaling pathways. The STAM2 molecule is involved in the regulation of cellular signaling pathways, including the PI3K/Akt signaling pathway.

The PI3K/Akt signaling pathway is a critical pathway involved in cell signaling that is involved in various cellular processes, including cell growth, differentiation, and survival. The STAM2 molecule has been shown to play a role in the regulation of this pathway by modulating the activity of the protein kinase B (PKB).

In addition to its involvement in the PI3K/Akt signaling pathway, the STAM2 molecule has also been shown to play a role in the regulation of other signaling pathways, including the NF-kappa signaling pathway. NF-kappa is a complex signaling pathway that is involved in cell growth, differentiation, and survival. The STAM2 molecule has been shown to play a role in the regulation of this pathway by modulating the activity of the transcription factor, p53.

The potential drug targets for STAM2 are numerous and include modulators of the PI3K/Akt signaling pathway, casein kinase (CK) 1 and 2, as well as the protein kinase B (PKB) and transcription factor, p53. These molecules have been shown to play a role in the regulation of various cellular processes, including cell growth, differentiation, and survival.

STAM2's Potential as a Biomarker

In addition to its potential as a drug target, the STAM2 molecule has also been identified as a potential biomarker. The STAM2 molecule is a protein that is expressed in various tissues, including the brain, heart, and gastrointestinal tract. It is primarily expressed in the cytoplasm and is localized to the endoplasmic reticulum (ER).

The STAM2 molecule has been shown to play a role in the regulation of various cellular processes, including the regulation of protein stability and the regulation of cellular signaling pathways. This suggests that the STAM2 molecule may be a useful biomarker for the diagnosis and prognosis of various diseases.

Conclusion

In conclusion, the STAM2 molecule has the potential to be a drug target and biomarker. Its unique structure and function, as well as its involvement in various cellular signaling pathways, make it an attractive target for drug development. Further research is needed to fully understand the role of the STAM2 molecule in cellular signaling pathways and its potential as a drug target and biomarker.

Protein Name: Signal Transducing Adaptor Molecule 2

Functions: Involved in intracellular signal transduction mediated by cytokines and growth factors. Upon IL-2 and GM-CSL stimulation, it plays a role in signaling leading to DNA synthesis and MYC induction. May also play a role in T-cell development. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with HGS (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes (By similarity)

The "STAM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STAM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

STAMBP | STAMBPL1 | STAP1 | STAP2 | STAR | STARD10 | STARD13 | STARD3 | STARD3NL | STARD4 | STARD4-AS1 | STARD5 | STARD6 | STARD7 | STARD7-AS1 | STARD8 | STARD9 | STARP1 | STAT1 | STAT2 | STAT3 | STAT4 | STAT4-AS1 | STAT5 | STAT5A | STAT5B | STAT6 | STATH | STAU1 | STAU2 | STAU2-AS1 | STBD1 | STC1 | STC2 | STEAP1 | STEAP1B | STEAP2 | STEAP2-AS1 | STEAP3 | STEAP3-AS1 | STEAP4 | STEEP1 | Steroid 5-alpha-Reductase | Sterol O-acyltransferase (ACAT) | Sterol Regulatory Element-Binding Protein | STH | STIL | STIM1 | STIM2 | STIMATE | STIN2-VNTR | STING1 | STIP1 | STK10 | STK11 | STK11IP | STK16 | STK17A | STK17B | STK19 | STK24 | STK25 | STK26 | STK3 | STK31 | STK32A | STK32A-AS1 | STK32B | STK32C | STK33 | STK35 | STK36 | STK38 | STK38L | STK39 | STK4 | STK4-DT | STK40 | STKLD1 | STMN1 | STMN2 | STMN3 | STMN4 | STMND1 | STMP1 | STN1 | STOM | STOML1 | STOML2 | STOML3 | STON1 | STON1-GTF2A1L | STON2 | Store-operating calcium channel channels | STOX1 | STOX2 | STPG1 | STPG2 | STPG3 | STPG3-AS1